CVS has natural hedges built in the business due to healthcare, managed care, and pharmacy: Analyst

Despite reporting better-than-expected fourth-quarter earnings results, CVS Health (CVS) had to cut its full-year outlook due to medical cost pressures.
Piper Sandler Healthcare Analyst Jessica Tassan tells Yahoo Finance Live that CVS’s “diversified business model” could help mitigate some of the impacts of Medicare Advantage costs. Looking ahead, she expects the pharmacy and consumer business segments to help offset some of the cost pressures associated with higher medical costs. Tassan expects this dynamic to continue throughout 2024 and become "even more compelling" in 2025.
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
- Get the latest news and data at finance.yahoo.com
- Download the Yahoo Finance app on Apple (apple.co/3Rten0R) or Android (bit.ly/3t8UnXO)
- Follow Yahoo Finance on social:
X: / yahoofinance
Instagram: yahoofinanc...
TikTok: www.tiktok.com/@yahoofinance?...
Facebook: / yahoofinance
LinkedIn: / yahoo-finance

[@blakeaaron5698]

CVS as a store is dead; they should downsize their footprint and just run a drive-thru pharmacy.

[@mariefisher-me4pb]

They push the COVID 19 SCAM

[@tydolla1539]

How can you rely on somebody to give you a thorough breakdown of a company they have no ownership in. If she wouldn’t invest in it then why give an analysis on it?

[@joesphreiley7757]

This video never mentions the single most money maker for CVS, they are partners with Sandoz Pharmaceutical to make and sell expensive Biosimilar prescription drugs for one third the price, bad video.

[@nick77353]

No one is talking about it, including CVS. Never show your cards until the timing is right and always keep an ace in your pocket.